Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

ReNerve (ASX:RNV): Nerve Repair Technology Targets Global Medical Device Opportunities

ReNerve Limited (ASX:RNV) is an Australian medical device company focused on developing products for peripheral nerve repair. Its lead product, the NervAlign Nerve Cuff, is a bioabsorbable wrap designed to support nerve healing following surgical repair. This article examines ReNerve’s technology platform and its …

Sonal Goyal | 18 September 2026

Vitasora Health (ASX:VHL): Remote Patient Monitoring Platform Targets US Healthcare Growth

Vitasora Health Limited (ASX:VHL) is a digital healthcare company focused on remote patient monitoring solutions. Formerly known as Respiri, the company has expanded its strategy from asthma monitoring towards a broader platform designed to support chronic disease management in the United States healthcare market. …

Sonal Goyal | 18 September 2026

Sigma Healthcare (ASX:SIG): FY26 Results Highlight Next Phase After Chemist Warehouse Merger

Sigma Healthcare Limited (ASX:SIG) is an Australian healthcare company operating as a pharmacy wholesaler and distributor, while also supporting retail pharmacy brands. Following its merger with Chemist Warehouse, the company has entered a new phase focused on integration, operational scale and delivering value from …

Sonal Goyal | 18 September 2026

Recce Pharmaceuticals (ASX:RCE): Anti-Infective Drug Development Focuses on Antibiotic Resistance

Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian clinical-stage biotechnology company developing synthetic anti-infective therapies designed to address bacterial infections, including those involving antibiotic-resistant strains. Its lead programme, RECCE 327, is being evaluated across topical, intravenous and inhaled formulations. This article examines the company’sDrug Developmentpathway …

Sonal Goyal | 18 September 2026

Immuron (ASX:IMC): Travelan Product Performance Supports Biopharmaceutical Strategy

Immuron Limited (ASX:IMC) is a Melbourne-based biopharmaceutical company focused on developing and commercialising antibody-based health products. The company’s main commercial product is Travelan, an oral supplement derived from bovine colostrum antibodies and marketed for reducing the risk of travellers’ diarrhoea. This article examines Travelan’s …

Sonal Goyal | 18 September 2026

Biome Australia (ASX:BIO): Probiotic Product Expansion Supports Consumer Health Strategy

Biome Australia Ltd (ASX:BIO) is a consumer health company focused on developing probiotic and supplement products. The company specialises in live biotherapeutic products and markets a range of clinically formulated probiotics through pharmacy and healthcare channels. This article examines how product launches,Manufacturingcapability and international …

Sonal Goyal | 18 September 2026

Biome Australia (ASX:BIO): Probiotic Product Expansion Supports Consumer Health Strategy

Biome Australia Ltd (ASX:BIO) is a consumer health company focused on developing probiotic and supplement products. The company specialises in live biotherapeutic products and markets a range of clinically formulated probiotics through pharmacy and healthcare channels. This article examines how product launches,Manufacturingcapability and international …

Sonal Goyal | 18 September 2026

PolyNovo (ASX:PNV): Synthetic Skin Repair Technology Supports Medical Device Expansion

PolyNovo Limited (ASX:PNV) is an Australian medical device company focused on developing synthetic solutions for complex wound and tissue repair. Its NovoSorb technology platform is designed to support skin regeneration following severe burns, trauma and other challenging wounds. This article examines how the company’s …

Sonal Goyal | 18 September 2026

Orthocell (ASX:OCC): Remplir Nerve Repair Technology Targets Global Medical Device Expansion

Orthocell Ltd (ASX:OCC) is an Australian regenerative medicine company developing products for nerve and tissue repair. Its lead medical device, Remplir, is a collagen nerve wrap designed to support surgical nerve repair. This article examines how the company is progressing from product development towards …

Sonal Goyal | 18 September 2026

Star Combo Pharma (ASX:S66): Supplement Manufacturing Capability Shapes Consumer Health Strategy

Star Combo Pharma Ltd (ASX:S66) is an Australian consumer health company focused on manufacturing and distributing vitamins, dietary supplements and skincare products. The company operates its own brands while also providing manufacturing services for other businesses. This article examines how its manufacturing capability supports …

Sonal Goyal | 18 September 2026
Support

Hi! How can we help you today?

Loading…